NCT03783091View on ClinicalTrials.gov

A Trial of Vitamin B12 in Septic Shock

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 5, 2019

Primary Completion Date

February 23, 2023

Study Completion Date

February 23, 2023

Conditions
Septic Shock
Interventions
DRUG

Hydroxocobalamin

Single IV administration of Vitamin B12

DRUG

Placebo

Single IV administration of saline

Trial Locations (1)

53226

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT03783091 - A Trial of Vitamin B12 in Septic Shock | Biotech Hunter | Biotech Hunter